Specific Inhibition of DNMT3A/ISGF3γ Interaction Increases the Temozolomide Efficiency to Reduce Tumor Growth

Mathilde Cheray 1, 2 Romain Pacaud 2, 1 Arulraj Nadaradjane 2, 1 Lisa Oliver 2, 1 François Vallette 3, 1, 2 Pierre-François Cartron 1, 3, 2, *
* Auteur correspondant
1 CRCNA - Centre de Recherche en Cancérologie / Nantes - Angers
2 Département de recherche en cancérologie
3 LabCT - Laboratoire de Biologie des Cancers et de Théranostic
Abstract : DNA methylation is a fundamental feature of genomes and is a candidate for pharmacological manipulation that might have important therapeutic advantage. Thus, DNA methyltransferases (DNMTs) appear to be ideal targets for drug intervention. By focusing on interactions existing between DNMT3A and DNMT3A-binding protein (D3A-BP), our work identifies the DNMT3A/ISGF3γ interaction such as a biomarker whose the presence level is associated with a poor survival prognosis and with a poor prognosis of response to the conventional chemotherapeutic treatment of glioblastoma multiforme (radiation plus temozolomide). Our data also demonstrates that the disruption of DNMT3A/ISGF3γ interactions increases the efficiency of chemotherapeutic treatment on established tumors in mice. Thus, our data opens a promising and innovative alternative to the development of specific DNMT inhibitors.
Keywords : GBM. glioma DNMT inhibitor DNMT epigenetic DNA methylation DNMT
Type de document :
Article dans une revue
Theranostics, Ivyspring International Publisher, 2016, 6, pp.1988 - 1999. 〈10.7150/thno.9150〉
Liste complète des métadonnées

Littérature citée [35 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-01414173
Contributeur : Elizabeth Bernardo <>
Soumis le : lundi 12 décembre 2016 - 10:35:43
Dernière modification le : jeudi 5 avril 2018 - 10:36:33
Document(s) archivé(s) le : mardi 28 mars 2017 - 00:54:28

Fichier

2016Art3Eq9.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

UNIV-NANTES | CRCNA

Citation

Mathilde Cheray, Romain Pacaud, Arulraj Nadaradjane, Lisa Oliver, François Vallette, et al.. Specific Inhibition of DNMT3A/ISGF3γ Interaction Increases the Temozolomide Efficiency to Reduce Tumor Growth. Theranostics, Ivyspring International Publisher, 2016, 6, pp.1988 - 1999. 〈10.7150/thno.9150〉. 〈inserm-01414173〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

181

Téléchargements de fichiers

137

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD